Achieve Life Sciences (ACHV) Deferred Taxes (2015 - 2017)
Achieve Life Sciences' (ACHV) quarterly Deferred Taxes came in at -$2.9 million in Q3 2017, down 2036.5% YoY from $151149.3 in Q3 2016, and down 2260.48% on a QoQ basis from -$124000.0 in Q1 2017.
Achieve Life Sciences (ACHV) Deferred Taxes (2015 - 2017) Analysis & Trends
Achieve Life Sciences (ACHV) has 3 years of Deferred Taxes data on file, last reported at -$2.9 million in Q3 2017.
- Quarterly Deferred Taxes fell 2036.5% year-over-year to -$2.9 million in Q3 2017, while the trailing twelve-month figure through Dec 2017 was -$3.2 million (down 530.56% YoY) and the FY2017 annual result came in at -$3.1 million, down 505.36% from the prior year.
- Deferred Taxes declined to -$2.9 million in Q3 2017, from -$124000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of -$118000.0 in Q1 2016 to a low of -$2.9 million in Q3 2017.
- A 3-year average of -$566000.0 and a median of -$127000.0 in 2016 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2016 — Deferred Taxes jumped 68.8% — and 2017, when it sank 2036.5%.
- Tracing ACHV's Deferred Taxes over 3 years: stood at -$407000.0 in 2015, then jumped by 68.8% to -$127000.0 in 2016, then tumbled by 2204.72% to -$2.9 million in 2017.
- The last three Deferred Taxes figures came in at -$2.9 million (Q3 2017), -$124000.0 (Q1 2017), and -$127000.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -2.93 Mn |
| Mar 31, 2017 | -124,000.00 |
| Dec 31, 2016 | -127,000.00 |
| Sep 30, 2016 | -137,000.00 |
| Jun 30, 2016 | -122,000.00 |
| Mar 31, 2016 | -118,000.00 |
| Dec 31, 2015 | -407,000.00 |